Compare OBT & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBT | LAB |
|---|---|---|
| Founded | 1892 | 1999 |
| Country | United States | United States |
| Employees | 225 | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.0M | 449.9M |
| IPO Year | N/A | 2011 |
| Metric | OBT | LAB |
|---|---|---|
| Price | $29.13 | $1.68 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $31.00 | $1.35 |
| AVG Volume (30 Days) | 33.0K | ★ 2.1M |
| Earning Date | 02-04-2026 | 11-04-2025 |
| Dividend Yield | ★ 1.74% | N/A |
| EPS Growth | ★ 18.38 | N/A |
| EPS | ★ 3.03 | N/A |
| Revenue | $115,418,000.00 | ★ $169,737,000.00 |
| Revenue This Year | $19.86 | N/A |
| Revenue Next Year | $7.20 | N/A |
| P/E Ratio | $9.86 | ★ N/A |
| Revenue Growth | 17.75 | ★ 79.77 |
| 52 Week Low | $20.97 | $0.92 |
| 52 Week High | $30.25 | $2.14 |
| Indicator | OBT | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 65.47 | 73.48 |
| Support Level | $28.95 | $1.46 |
| Resistance Level | $30.25 | $1.51 |
| Average True Range (ATR) | 0.78 | 0.08 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 66.26 | 87.88 |
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.